1. Home
  2. STRO vs GSIT Comparison

STRO vs GSIT Comparison

Compare STRO & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • GSIT
  • Stock Information
  • Founded
  • STRO 2003
  • GSIT 1995
  • Country
  • STRO United States
  • GSIT United States
  • Employees
  • STRO N/A
  • GSIT N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • GSIT Semiconductors
  • Sector
  • STRO Health Care
  • GSIT Technology
  • Exchange
  • STRO Nasdaq
  • GSIT Nasdaq
  • Market Cap
  • STRO 50.0M
  • GSIT 58.5M
  • IPO Year
  • STRO 2018
  • GSIT N/A
  • Fundamental
  • Price
  • STRO $0.52
  • GSIT $2.61
  • Analyst Decision
  • STRO Buy
  • GSIT
  • Analyst Count
  • STRO 7
  • GSIT 0
  • Target Price
  • STRO $6.83
  • GSIT N/A
  • AVG Volume (30 Days)
  • STRO 1.4M
  • GSIT 170.6K
  • Earning Date
  • STRO 05-12-2025
  • GSIT 05-01-2025
  • Dividend Yield
  • STRO N/A
  • GSIT N/A
  • EPS Growth
  • STRO N/A
  • GSIT N/A
  • EPS
  • STRO N/A
  • GSIT N/A
  • Revenue
  • STRO $62,043,000.00
  • GSIT $19,787,000.00
  • Revenue This Year
  • STRO N/A
  • GSIT N/A
  • Revenue Next Year
  • STRO $1.29
  • GSIT N/A
  • P/E Ratio
  • STRO N/A
  • GSIT N/A
  • Revenue Growth
  • STRO N/A
  • GSIT N/A
  • 52 Week Low
  • STRO $0.54
  • GSIT $1.62
  • 52 Week High
  • STRO $5.17
  • GSIT $4.90
  • Technical
  • Relative Strength Index (RSI)
  • STRO 29.82
  • GSIT 54.57
  • Support Level
  • STRO $0.54
  • GSIT $1.62
  • Resistance Level
  • STRO $0.78
  • GSIT $2.85
  • Average True Range (ATR)
  • STRO 0.09
  • GSIT 0.22
  • MACD
  • STRO 0.02
  • GSIT 0.09
  • Stochastic Oscillator
  • STRO 0.00
  • GSIT 80.49

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: